Developer docs
API playgroundTry for free, no card

Search company profiles

Arogya Finance

Full company profile

uuid000ekxs

Namestring
Arogya Finance
Legal namestring
Ramtirth Leasing and Finance Company Pvt. Ltd.
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Arogya Finance is an Indian NBFC (operating under the legal entity Ramtirth Leasing and Finance Company Pvt. Ltd., RBI Registration No. 13.01234) that provides medical loans to financially underserved borrowers who lack access to formal banking channels. Co-founded by Jose Peter (CEO) and Dheeraj Batra and headquartered in Mumbai, the company targets informal sector borrowers without salary slips, formal credit history, or collateral, using proprietary risk assessment tools developed specifically for this population. Distribution is anchored by a network of 2,400+ hospital partners across 800+ cities in 20+ Indian states, supplemented by 9 Regional Financial Counsellors covering every major Indian region and direct-to-consumer online applications.

The product portfolio comprises four offerings: a Standard Loan for immediate medical emergencies (disbursed directly to hospitals, with tenures up to 4 years and repayment via post-dated checks), a Pre-approved Arogya Card offering up to Rs 5 lakhs of pre-approved credit covering 75% of medical bills at any partner hospital, a specialized Cancer Loan (Oncology) covering up to Rs 25 lakhs at 0% interest in most cases via a digital 5-minute KYC-only application, and an internal Loan Origination System (LOS) web platform supporting end-to-end digital loan workflows. Underlying technology includes the proprietary risk assessment methodology, a digital LOS, and integrations with manufacturer and hospital partner systems enabling direct disbursement and EMI management.

Arogya Finance generates revenue primarily through interest on medical loans, a 2% one-time processing fee, and a Rs 500 documentation charge. A material share of loan volume (cancer, prosthetics, certain ophthalmology and bariatric programs) is offered at 0% interest, with the spread subsidized by manufacturer partners such as Bayer, Roche, Medtronic, Johnson & Johnson, Dr. Reddy's, Ottobock, and Cochlear. The company operates a hybrid go-to-market combining online direct application with hospital-partner-driven acquisition, and relies on Aditya Birla Finance Ltd as a core lending partner to scale disbursement capacity. Customer segments span informal sector borrowers, family members financing dependents, oncology patients, and elective treatment seekers across cardiology, orthopedics, gastroenterology, urology, cosmetic surgery, spine, transplants, fertility, and dental specialties.

Short descriptiontext

Arogya Finance is an India-based RBI-registered NBFC that provides medical loans to financially underserved borrowers lacking formal documentation or collateral, distributed via 2,400+ hospital partners and proprietary risk assessment tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical loans, healthcare financing, patient lending, NBFC lending, risk assessment
Industry3 codes
1Medical & Healthcare Personal Loans (Unsecured Installment)
CodeFSAKAAAFPrimaryYes
2Healthcare & Medical POS Financing
CodeFSAKAFAIPrimaryNo
3Emergency & Short-Term Installment Personal Loans (Unsecured)
CodeFSAKAAAHPrimaryNo
NAICS code1 code
  • Credit Intermediation and Related Activities522
SIC code1 code
  • Personal Credit Institutions6141
Product category
Healthcare Financing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Loan Interest
TypeTransaction Fee
Description

Arogya Finance generates revenue through interest charged on medical loans. The company offers loans for various medical treatments with EMI options. Processing fees of 2% and documentation charges of Rs 500 apply. Some loans (e.g., cancer loans, prosthetics) are offered at 0% interest in many cases, suggesting partnerships with hospitals or manufacturers who subsidize or buy down the interest.

arogyafinance.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Standard Medical Loan - Flexible loan amounts for general medical treatments
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

Loan amount not capped; determined by affordability assessment. Documentation charge Rs 500 + 2% processing fee. Tenure flexible up to 4 years.

arogyafinance.com
2Pre-approved Arogya Card - Medical loan card up to Rs 5 lakhs
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

Pre-approved loan up to Rs 5 lakhs. Covers up to 75% of medical bill. Can be used at any hospital.

arogyafinance.com
3Cancer Loan (Oncology) - Up to Rs 25 lakhs for cancer treatment
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

Interest Free* in most cases. Tenure 3-36 months. Loan amount up to Rs 25 lakhs covering up to 100% of treatment cost. Quick disbursal with digital process requiring only KYC.

arogyafinance.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Arogya Card
Description

Pre-approved medical loan card offering medical loans up to Rs 5 lakhs for future medical emergencies.

arogyafinance.com
+1 more record
Core offering1 text field

Arogya Finance is an NBFC providing medical loans to traditionally un-bankable populations in India who lack formal income documentation or collateral. The company offers Standard Loans for immediate medical emergencies, Pre-approved Arogya Cards for future medical needs, and specialized Cancer Loans up to Rs 25 lakhs, with funds disbursed directly to hospitals across a 2400+ hospital partner network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 3-hour average loan approval time, can be as fast as 3 hours in emergencies
+3 more records
Product overview1 text field

Arogya Finance is a social healthcare NBFC (brand name of Ramtirth Leasing and Finance Company Pvt. Ltd.) offering medical loans to underserved populations in India who lack access to traditional banking. The product portfolio centers on three core offerings: the Standard Loan for immediate medical emergencies, the Pre-approved Loan (Arogya Card) providing card-based pre-approved credit up to Rs. 5 lakhs for future medical needs, and the specialized Cancer Loan (Oncology) covering cancer treatment costs with loan amounts up to Rs. 25 lakhs at 0% interest. All products are supported by a proprietary Loan Origination System (LOS) platform for digital application processing, and are distributed through a network of 2400+ hospital partners across 800+ cities in 20+ Indian states.

Product and service3 records
1Standard Loan
CategoryMedical Loan
Description

A medical loan product for immediate medical emergencies covering any type of treatment or surgery. Loan disbursement is made directly to the hospital, with tenures up to 4 years and repayment via post-dated checks or alternate options.

2Pre-approved Arogya Card
CategoryMedical Loan Card
Description

A pre-approved medical loan card enabling borrowers to access credit up to Rs 5 lakhs for future medical emergencies, covering up to 75% of the medical bill. The card facilitates treatment at any hospital within the partner network without requiring full upfront payment.

3Cancer Loan (Oncology)
CategorySpecialty Medical Loan
Description

A specialized medical loan product for cancer treatment covering surgery, immunotherapy, targeted therapy, chemotherapy, genomic testing, and diagnostics. Features 0% interest in most cases, tenure flexibility of 3–36 months, loan amounts up to Rs 25 lakhs covering up to 100% of treatment cost, and a fully digital 5-minute application requiring only KYC documents.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Medtronic Diabetes offers an integrated system combining insulin pumps and Continuous Glucose Monitoring. Arogya Finance provides financing for Medtronic diabetes treatment devices.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

J&J has contributed significantly to advancing bariatric surgery and obesity treatment science. Arogya Finance provides financing options for J&J bariatric procedures.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading multinational pharmaceutical company committed to affordable medicines. Partnership provides medical loans for hepatitis C treatment and other Dr. Reddy's therapies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

German multinational pharmaceutical company. Partnership includes Eylea Easy Pay Program for diabetic macular oedema and wet AMD treatment financing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

90+ years of experience in mobility solutions. Provides hi-tech and affordable artificial limbs. Arogya Finance offers 0% interest loans for prosthetics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading pharmaceutical company in oncology, investing in personalized immunotherapy for cancer patients. Arogya Finance provides cancer treatment financing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global leader in hearing implant systems. Partnership provides financing for cochlear implant surgeries.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pioneer in personalized home healthcare services in India, offering convenient recovery within comfort of home.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Provides new hope for cancer patients. Arogya Finance offers treatment financing.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

World-class fertility treatments with cutting edge tools and German doctors, offering result-oriented and cost-effective plans.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Works with 350+ hearing care professionals across India. Uses state-of-art equipment to test hearing and recommend hearing aids.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major hospital chain with 23+ locations. Patients can avail Arogya Finance medical loans at Narayana Health facilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Devices for treating sleep apnea, designed to optimize patient comfort and compliance.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of India's largest consumer NBFCs, offering the Bajaj Finserv Health EMI card and extensive no-cost EMI options across hospitals. Comparable as a mass-market medical financing provider, though it operates across many consumer categories rather than specializing in un-bankable borrowers.

TypeDirect peer
Description

India-based digital lending fintech focused on consumer finance for underserved, thin-file borrowers without formal credit history. Closely comparable business model: EMI-based lending to the un-bankable for big-ticket purchases, distributed through merchant networks.

TypeDirect peer
Description

Digital lender providing instant personal loans to salaried informal-sector workers and students in India. Comparable as a digital-first lender serving underbanked Indian borrowers with non-traditional underwriting.

TypeDirect peer
Description

Digital lending platform offering short-term personal credit to young professionals and informal salaried borrowers in India. Comparable customer segment (underbanked Indian consumers) and digital-led origination model.

TypeDirect peer
Description

App-based personal credit line provider targeting Indian consumers, including those with limited credit history. Comparable as a consumer digital lender serving underbanked Indians.

TypeDirect peer
Description

HDFC Group's NBFC specializing in education and livelihood loans for underserved Indian borrowers. Comparable niche (purpose-specific lending to un-bankable) and India NBFC regulatory structure.

TypeDirect peer
Description

Listed Indian microfinance NBFC focused on small-ticket credit to rural and informal-sector women borrowers. Comparable as an NBFC serving India's un-bankable population with non-traditional underwriting.

TypeDirect peer
Description

Large Indian microfinance institution providing income-generation and consumption loans to underbanked rural households. Comparable as a regulated Indian lender to the un-bankable with proprietary underwriting.

TypeBroad incumbent
Description

Diversified Indian NBFC offering consumer loans including medical financing products. Comparable as a broader- portfolio NBFC competing in medical lending with lower-cost capital and stronger brand.

TypeDirect peer
Description

Indian digital lending platform partnering with merchants and healthcare providers to offer instant consumer credit to thin-file borrowers. Closely comparable merchant-partner-led medical/instant-credit model for underbanked Indian consumers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arogya Finance

Healthcare Financingarogyafinance.com

Arogya Finance is an India-based RBI-registered NBFC that provides medical loans to financially underserved borrowers lacking formal documentation or collateral, distributed via 2,400+ hospital partners and proprietary risk assessment tools.

What Arogya Finance does

Arogya Finance is an Indian NBFC (operating under the legal entity Ramtirth Leasing and Finance Company Pvt. Ltd., RBI Registration No. 13.01234) that provides medical loans to financially underserved borrowers who lack access to formal banking channels. Co-founded by Jose Peter (CEO) and Dheeraj Batra and headquartered in Mumbai, the company targets informal sector borrowers without salary slips, formal credit history, or collateral, using proprietary risk assessment tools developed specifically for this population. Distribution is anchored by a network of 2,400+ hospital partners across 800+ cities in 20+ Indian states, supplemented by 9 Regional Financial Counsellors covering every major Indian region and direct-to-consumer online applications.

The product portfolio comprises four offerings: a Standard Loan for immediate medical emergencies (disbursed directly to hospitals, with tenures up to 4 years and repayment via post-dated checks), a Pre-approved Arogya Card offering up to Rs 5 lakhs of pre-approved credit covering 75% of medical bills at any partner hospital, a specialized Cancer Loan (Oncology) covering up to Rs 25 lakhs at 0% interest in most cases via a digital 5-minute KYC-only application, and an internal Loan Origination System (LOS) web platform supporting end-to-end digital loan workflows. Underlying technology includes the proprietary risk assessment methodology, a digital LOS, and integrations with manufacturer and hospital partner systems enabling direct disbursement and EMI management.

Arogya Finance generates revenue primarily through interest on medical loans, a 2% one-time processing fee, and a Rs 500 documentation charge. A material share of loan volume (cancer, prosthetics, certain ophthalmology and bariatric programs) is offered at 0% interest, with the spread subsidized by manufacturer partners such as Bayer, Roche, Medtronic, Johnson & Johnson, Dr. Reddy's, Ottobock, and Cochlear. The company operates a hybrid go-to-market combining online direct application with hospital-partner-driven acquisition, and relies on Aditya Birla Finance Ltd as a core lending partner to scale disbursement capacity. Customer segments span informal sector borrowers, family members financing dependents, oncology patients, and elective treatment seekers across cardiology, orthopedics, gastroenterology, urology, cosmetic surgery, spine, transplants, fertility, and dental specialties.

Arogya Finance firmographics

Firmographics
Name
Arogya Finance
Legal name
Ramtirth Leasing and Finance Company Pvt. Ltd.
Website
https://arogyafinance.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Arogya Finance is an India-based RBI-registered NBFC that provides medical loans to financially underserved borrowers lacking formal documentation or collateral, distributed via 2,400+ hospital partners and proprietary risk assessment tools.
Ownership category
akta.pro rank

Arogya Finance industry classification

Industry
Product category
Healthcare Financing
NAICS
Credit Intermediation and Related Activities (522)
SIC
Personal Credit Institutions (6141)
akta.pro primary industry
Medical & Healthcare Personal Loans (Unsecured Installment) (FSAKAAAF)
akta.pro secondary industries
Healthcare & Medical POS Financing (FSAKAFAI), Emergency & Short-Term Installment Personal Loans (Unsecured) (FSAKAAAH)

Keywords

  • Medical loans
  • Healthcare financing
  • Patient lending
  • NBFC lending
  • Risk assessment

Where Arogya Finance is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Arogya Finance business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Loan Interest: Arogya Finance generates revenue through interest charged on medical loans. The company offers loans for various medical treatments with EMI options. Processing fees of 2% and documentation charges of Rs 500 apply. Some loans (e.g., cancer loans, prosthetics) are offered at 0% interest in many cases, suggesting partnerships with hospitals or manufacturers who subsidize or buy down the interest.

Pricing tiers

ModelBillingPrice
Transaction based/ take rateMonthlyStandard Medical Loan - Flexible loan amounts for general medical treatments
Transaction based/ take rateMonthlyPre-approved Arogya Card - Medical loan card up to Rs 5 lakhs
Transaction based/ take rateMonthlyCancer Loan (Oncology) - Up to Rs 25 lakhs for cancer treatment

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Arogya Finance product offering

Product offering

Core offering

Arogya Finance is an NBFC providing medical loans to traditionally un-bankable populations in India who lack formal income documentation or collateral. The company offers Standard Loans for immediate medical emergencies, Pre-approved Arogya Cards for future medical needs, and specialized Cancer Loans up to Rs 25 lakhs, with funds disbursed directly to hospitals across a 2400+ hospital partner network.

Product overview

Arogya Finance is a social healthcare NBFC (brand name of Ramtirth Leasing and Finance Company Pvt. Ltd.) offering medical loans to underserved populations in India who lack access to traditional banking. The product portfolio centers on three core offerings: the Standard Loan for immediate medical emergencies, the Pre-approved Loan (Arogya Card) providing card-based pre-approved credit up to Rs. 5 lakhs for future medical needs, and the specialized Cancer Loan (Oncology) covering cancer treatment costs with loan amounts up to Rs. 25 lakhs at 0% interest. All products are supported by a proprietary Loan Origination System (LOS) platform for digital application processing, and are distributed through a network of 2400+ hospital partners across 800+ cities in 20+ Indian states.

Differentiator

Problem solved

Functional benefit

Brands

  • Arogya Card: Pre-approved medical loan card offering medical loans up to Rs 5 lakhs for future medical emergencies.
  • Cancer Loan (Oncology)

Products and services

  • Standard Loan A medical loan product for immediate medical emergencies covering any type of treatment or surgery. Loan disbursement is made directly to the hospital, with tenures up to 4 years and repayment via post-dated checks or alternate options.
  • Pre-approved Arogya Card A pre-approved medical loan card enabling borrowers to access credit up to Rs 5 lakhs for future medical emergencies, covering up to 75% of the medical bill. The card facilitates treatment at any hospital within the partner network without requiring full upfront payment.
  • Cancer Loan (Oncology) A specialized medical loan product for cancer treatment covering surgery, immunotherapy, targeted therapy, chemotherapy, genomic testing, and diagnostics. Features 0% interest in most cases, tenure flexibility of 3–36 months, loan amounts up to Rs 25 lakhs covering up to 100% of treatment cost, and a fully digital 5-minute application requiring only KYC documents.

Quantifiable outcome

  • 3-hour average loan approval time, can be as fast as 3 hours in emergencies
  • +3 more outcomes

Companies that use Arogya Finance

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Arogya Finance technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Arogya Finance partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • Medtronic DiabetescoreStrategic or Co-development PartnerMedtronic Diabetes offers an integrated system combining insulin pumps and Continuous Glucose Monitoring. Arogya Finance provides financing for Medtronic diabetes treatment devices.
  • Johnson & JohnsoncoreStrategic or Co-development PartnerJ&J has contributed significantly to advancing bariatric surgery and obesity treatment science. Arogya Finance provides financing options for J&J bariatric procedures.
  • Dr. Reddy's LaboratoriescoreStrategic or Co-development PartnerLeading multinational pharmaceutical company committed to affordable medicines. Partnership provides medical loans for hepatitis C treatment and other Dr. Reddy's therapies.
  • BayercoreStrategic or Co-development PartnerGerman multinational pharmaceutical company. Partnership includes Eylea Easy Pay Program for diabetic macular oedema and wet AMD treatment financing.
  • OttobockcoreStrategic or Co-development Partner90+ years of experience in mobility solutions. Provides hi-tech and affordable artificial limbs. Arogya Finance offers 0% interest loans for prosthetics.
  • RochecoreStrategic or Co-development PartnerLeading pharmaceutical company in oncology, investing in personalized immunotherapy for cancer patients. Arogya Finance provides cancer treatment financing.
  • CochlearcoreStrategic or Co-development PartnerGlobal leader in hearing implant systems. Partnership provides financing for cochlear implant surgeries.
  • Healthcare at HOMEminorStrategic or Co-development PartnerPioneer in personalized home healthcare services in India, offering convenient recovery within comfort of home.
  • Boehringer IngelheimminorStrategic or Co-development PartnerProvides new hope for cancer patients. Arogya Finance offers treatment financing.
  • Morpheus IVFminorStrategic or Co-development PartnerWorld-class fertility treatments with cutting edge tools and German doctors, offering result-oriented and cost-effective plans.
  • Hear.comminorStrategic or Co-development PartnerWorks with 350+ hearing care professionals across India. Uses state-of-art equipment to test hearing and recommend hearing aids.
  • Narayana HealthcoreChannel Partner/ Reseller/ DistributorMajor hospital chain with 23+ locations. Patients can avail Arogya Finance medical loans at Narayana Health facilities.
  • SEFAMminorStrategic or Co-development PartnerDevices for treating sleep apnea, designed to optimize patient comfort and compliance.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Arogya Finance competitors and assessment

Company assessment

Broad incumbents

  • Bajaj Finserv: One of India's largest consumer NBFCs, offering the Bajaj Finserv Health EMI card and extensive no-cost EMI options across hospitals. Comparable as a mass-market medical financing provider, though it operates across many consumer categories rather than specializing in un-bankable borrowers.
  • Tata Capital: Diversified Indian NBFC offering consumer loans including medical financing products. Comparable as a broader- portfolio NBFC competing in medical lending with lower-cost capital and stronger brand.

Direct peers

  • ZestMoney: India-based digital lending fintech focused on consumer finance for underserved, thin-file borrowers without formal credit history. Closely comparable business model: EMI-based lending to the un-bankable for big-ticket purchases, distributed through merchant networks.
  • mPokket: Digital lender providing instant personal loans to salaried informal-sector workers and students in India. Comparable as a digital-first lender serving underbanked Indian borrowers with non-traditional underwriting.
  • CASHe: Digital lending platform offering short-term personal credit to young professionals and informal salaried borrowers in India. Comparable customer segment (underbanked Indian consumers) and digital-led origination model.
  • MoneyTap: App-based personal credit line provider targeting Indian consumers, including those with limited credit history. Comparable as a consumer digital lender serving underbanked Indians.
  • HDFC Credila Financial Services: HDFC Group's NBFC specializing in education and livelihood loans for underserved Indian borrowers. Comparable niche (purpose-specific lending to un-bankable) and India NBFC regulatory structure.
  • Spandana Sphoorty Finance: Listed Indian microfinance NBFC focused on small-ticket credit to rural and informal-sector women borrowers. Comparable as an NBFC serving India's un-bankable population with non-traditional underwriting.
  • CreditAccess Grameen: Large Indian microfinance institution providing income-generation and consumption loans to underbanked rural households. Comparable as a regulated Indian lender to the un-bankable with proprietary underwriting.
  • Kissht: Indian digital lending platform partnering with merchants and healthcare providers to offer instant consumer credit to thin-file borrowers. Closely comparable merchant-partner-led medical/instant-credit model for underbanked Indian consumers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Arogya Finance social profiles

Digital presence

Arogya Finance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arogya Finance leadership team

Management profile

Number of profiles

Profiles2 records

Arogya Finance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arogya Finance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arogya Finance

What does Arogya Finance do?

Arogya Finance is an NBFC providing medical loans to traditionally un-bankable populations in India who lack formal income documentation or collateral. The company offers Standard Loans for immediate medical emergencies, Pre-approved Arogya Cards for future medical needs, and specialized Cancer Loans up to Rs 25 lakhs, with funds disbursed directly to hospitals across a 2400+ hospital partner network.

Is Arogya Finance a public or private company?

Arogya Finance is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Arogya Finance founded?

Arogya Finance was founded in 1995. It employs 11 to 50 people.

Where is Arogya Finance based?

Arogya Finance is headquartered in Mumbai, India, in the Asia region.

How does Arogya Finance make money?

One revenue line is on record: medical Loan Interest.

Who are Arogya Finance's main competitors?

Broad incumbents on record are Bajaj Finserv and Tata Capital. Direct peers are ZestMoney, mPokket, CASHe, MoneyTap, HDFC Credila Financial Services, Spandana Sphoorty Finance, CreditAccess Grameen and Kissht.

Does Arogya Finance have an API?

No public API is recorded for Arogya Finance.

What industry is Arogya Finance in?

Arogya Finance's product category is Healthcare Financing. Its primary akta.pro industry code is FSAKAAAF, Medical & Healthcare Personal Loans (Unsecured Installment), with a secondary code of FSAKAFAI, Healthcare & Medical POS Financing. Its NAICS code is 522 and its SIC code is 6141.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
https://www.outlookbusiness.com/Healthcare Affordability: The Financing Gap Beyond Insurance – Jose Peter, Co-Founder & CEO, Arogya Finance – Outlook BusinessHealthcare affordability in India requires financing beyond insurance, as treatment costs often exceed coverage. Arogya Finance offers digital assessment and EMI options to bridge gaps. Policymakers should consider financing as part of affordability infrastructure.The Times of India<b>Immuneel’s global CAR-T bet starts with manufacturing in India</b>Bengaluru-based clinical-stage biotech startup Immuneel Therapeutics has built India’s first GMP CAR-T manufacturing facility, capable of serving 500–800 patients annually, and is now treating patients while planning to expand for export to global markets. The company is pursuing cost reduction through process optimization, input localization of cytokines and reagents, and broader access partnerships including zero-cost loans through Arogya Finance and crowdfunding via Patguru, to address the absence of reimbursement architecture for CAR-T therapies in India. CEO Amit Mookim defines success as creating a world-class CAR-T product validated by global markets, built by Indian scientists, to demonstrate India’s manufacturing know-how and scientific talent.The Times of IndiaGene therapy firm Immuneel ties up with Arogya Finance to offer ₹25 lakh zero-cost EMI for cancer treatment, ETManufacturingImmuneel Therapeutics has partnered with Mumbai-based NBFC Arogya Finance to launch a zero-cost EMI financing programme of up to ₹25 lakh for eligible patients undergoing advanced cancer treatment under its Saksham Patient Access Program. Eligible patients can access interest-free installments for up to 12 months, subject to credit assessment and lender approval, to reduce financial barriers and treatment delays. The initiative aims to improve access to advanced gene therapies by allowing patients to begin therapy without needing to arrange the full treatment cost upfront.The Times of IndiaGene therapy firm Immuneel ties up with Arogya Finance to offer Rs 25 lakh zero-cost EMI for cancer treatment - The Economic TimesImmuneel Therapeutics, a Bengaluru-based cell and gene therapy company, has partnered with Mumbai-based NBFC Arogya Finance to launch a zero-cost EMI programme for advanced cancer treatments worth up to Rs 25 lakh. The financing initiative, rolled out under Immuneel's Saksham Patient Access Program, enables eligible patients to access interest-free EMIs for up to 12 months, subject to credit assessment and lender approval. The partnership aims to reduce delays in treatment caused by financial constraints by allowing patients to pay in installments rather than bearing the full treatment cost upfront.Business News TodayEMIs for Botox and Fillers: Fintechs tap into India's cosmetic lending boom with easy loansFintech companies including Fibe, SaveIN, QubeHealth, and Arogya Finance are aggressively expanding into India's cosmetic and aesthetic procedure financing market by offering easy EMI options for treatments ranging from Botox to hair transplants. Fibe alone disburses approximately Rs 20 crore monthly in wellness loans through partnered clinics, while the beauty and cosmetic procedures market in India is estimated at $1.5–2 billion and growing at 25% year-over-year. The trend is driven by shifting consumer attitudes, with treatments becoming normalized among salaried millennials and even Gen Z borrowers as young as 21, and fintechs reporting lower delinquency rates in this discretionary spending category compared to traditional unsecured personal loans.